Structure Therapeutics Inc ADR (NASDAQ: GPCR) on Monday, plunged -5.94% from the previous trading day, before settling in for the closing price of $23.75. Within the past 52 weeks, GPCR’s price has moved between $19.61 and $62.74.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 6.55%. With a float of $54.47 million, this company’s outstanding shares have now reached $57.29 million.
Let’s determine the extent of company efficiency that accounts for 163 employees. In terms of profitability, gross margin is 11.91%, operating margin of -10705.09%, and the pretax margin is -8335.45%.
Structure Therapeutics Inc ADR (GPCR) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Structure Therapeutics Inc ADR is 4.91%, while institutional ownership is 102.75%.
Structure Therapeutics Inc ADR (GPCR) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 6.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -25.24% during the next five years compared to -51.75% drop over the previous five years of trading.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Trading Performance Indicators
Structure Therapeutics Inc ADR (GPCR) is currently performing well based on its current performance indicators. A quick ratio of 24.74 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.32, a number that is poised to hit -0.24 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Structure Therapeutics Inc ADR (GPCR)
Looking closely at Structure Therapeutics Inc ADR (NASDAQ: GPCR), its last 5-days average volume was 1.2 million, which is a jump from its year-to-date volume of 0.83 million. As of the previous 9 days, the stock’s Stochastic %D was 62.77%. Additionally, its Average True Range was 1.96.
During the past 100 days, Structure Therapeutics Inc ADR’s (GPCR) raw stochastic average was set at 11.45%, which indicates a significant decrease from 46.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 95.86% in the past 14 days, which was higher than the 73.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $26.69, while its 200-day Moving Average is $35.89. However, in the short run, Structure Therapeutics Inc ADR’s stock first resistance to watch stands at $23.46. Second resistance stands at $24.59. The third major resistance level sits at $25.40. If the price goes on to break the first support level at $21.52, it is likely to go to the next support level at $20.71. Should the price break the second support level, the third support level stands at $19.58.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Key Stats
Market capitalization of the company is 1.28 billion based on 57,261K outstanding shares. Right now, sales total 0 K and income totals -89,620 K. The company made 0 K in profit during its latest quarter, and -33,980 K in sales during its previous quarter.
